6 completed. 6 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 6 | Completed 6 |
| Phase 2 | 1 | Completed 1 |
Follow FluBlok: new trials by email Literature Review of FluBlok trials Research Report on FluBlok
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of VAX-31 With Influenza Vaccine in Adults ≥ 50 Years of Age 31-valent pneumococcal conjugate vaccine, Seasonal Influenza Vaccine (SIV) (Flublok), Placebo - Pneumococcal Disease | Phase 3 | Completed | Vaxcyte, Inc. | 1390 | 2026-01-12 | 2026-11-13 |
| Comparison of the Safety of Flublok® Versus Licensed IIV in Healthy, Medically Stable Adults ≥ 50 Years of Age Flublok, Afluria - Influenza | Phase 3 | Completed | Protein Sciences Corporation | 2640 | 2013-03-01 | 2015-02-18 |
| Immunogenicity, Safety, Reactogenicity, Efficacy, Effectiveness and Lot Consistency of FluBlok FluBlok®, Placebo - Influenza | Phase 3 | Completed | Sanofi | 4648 | 2007-09-15 | 2022-04-06 |
| Safety and Reactogenicity of FluBlok and Comparison of Immunogenicity, Efficacy and Effectiveness Against TIV FluBlok Influenza Vaccination, TIV (Fluzone) Influenza Vaccination - Influenza | Phase 3 | Completed | Protein Sciences Corporation | 602 | 2007-09-01 | 2011-07-27 |
| Comparison of the Immunogenicity, Safety and Reactogenicity of FluBlok, To a Licensed Vaccine In Elderly Adults Influenza Vaccination - Influenza | Phase 3 | Completed | Protein Sciences Corporation | 870 | 2006-10-01 | 2009-12-17 |
| Immunogenicity and Safety of Trivalent Recombinant Hemagglutinin Influenza Vaccine in Healthy Adults Influenza Vaccine, recombinant Hemagglutinin - Influenza | Phase 2 / Phase 3 | Completed | Protein Sciences Corporation | 459 | 2004-11-01 | 2010-01-12 |
Influenza, Human (5) · Pneumococcal Infections (1) · Pneumonia (1)
Protein Sciences Corporation (4) · Sanofi (1) · Vaxcyte, Inc. (1)
United States (6)
Alan C. Wine, MD (1) · Bob Weiss, MD (1) · Brandon Essink, MD (1) · Darrell Herrington, DO (1) · Eric Sheldon (1) · Frank Eder, MD (1) · George Bauer, MD (1) · Gregory A. Poland, MD (1) · Hana M. El-Sahly, MD (1) · Jeffrey Rosen, MD (1) · Joe Blumenau, MD (1) · John J Treanor, MD (1) · John J. Minneti, MD (1) · John J. Treanor, MD (1) · John Treanor, MD (1)
PMID 26787832, PMID 28325769, PMID 17426277, PMID 19879222, PMID 21277410, PMID 26529070